Grant: Engage Grants Program
University of Waterloo
$25,000.00
Wireless Surface Enhannced Raman Spectroscopy (mSERS)
EF 2014-15
Résumé
Definitive diagnoses for cancers are typically based upon histological examination of a biopsy, however to take a biopsy, the cancer must be visible to current detection methodologies. BioMark's approach for the detection of pre-visible / pre-symptomatic cancer, by identifying the chemical signature of the acetylation process corresponding to the up regulation of SSAT1 in the presence of cancer, represents the next generation of early cancer tests.The objective of this project is to innovate a new generation of mobile cancer test laboratories by transforming a novel Surface Enhanced Raman Spectrometer to become the first-in-world mSERS with detailed performance specifications to allow the use of the BlackBerry as a User Interface for a Medical Device.This technology integration is unique and will dramatically decrease the need for highly trained personnel to perform analytical chemistry functions. It will reduce the complexity of conducting clinical studies worldwide, gathering valuable information to improve the diagnostic accuracy of BioMark's product offerings. The long-term goal of achieving diagnostic accuracy approaching histopathology gold standards with pre-visible and pre-symptomatic cancers will revolutionize early cancer detection and as a result, save lives.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
476430-2014
Name nom
SafaviNaeini, Safieddin
Department département
Electrical & Computer Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
2525
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Wireless communication systems
Research subject fr
Systèmes de télécommunications sans fil
Partie
1
Nb partie
1
Application title
Wireless Surface Enhannced Raman Spectroscopy (mSERS)
Keyword
NSERC
Application summary
Definitive diagnoses for cancers are typically based upon histological examination of a biopsy, however to take a biopsy, the cancer must be visible to current detection methodologies. BioMark's approach for the detection of pre-visible / pre-symptomatic cancer, by identifying the chemical signature of the acetylation process corresponding to the up regulation of SSAT1 in the presence of cancer, represents the next generation of early cancer tests.The objective of this project is to innovate a new generation of mobile cancer test laboratories by transforming a novel Surface Enhanced Raman Spectrometer to become the first-in-world mSERS with detailed performance specifications to allow the use of the BlackBerry as a User Interface for a Medical Device.This technology integration is unique and will dramatically decrease the need for highly trained personnel to perform analytical chemistry functions. It will reduce the complexity of conducting clinical studies worldwide, gathering valuable information to improve the diagnostic accuracy of BioMark's product offerings. The long-term goal of achieving diagnostic accuracy approaching histopathology gold standards with pre-visible and pre-symptomatic cancers will revolutionize early cancer detection and as a result, save lives.